Characteristics of 1196 patients with a detectable HCV-RNA, according to HCV-treatment status (patients under HCV treatment at the time of analysis and patients with HCV reinfection excluded).

CDC: Centers for Disease Control; IQR: interquartile range; ART: antiretroviral treatment; NRTI: nucleoside/nucleotide reverse transcriptase inhibitor; bPI: ritonavir-boosted protease inhibitor; NNRTI: non-nucleoside reverse transcriptase inhibitor; INSTI: integrase strand transfer inhibitor. * Creatinine clearance estimated using the Cockcroft-Gault Equation: creatinine clearance = (140 –age (years)) / weight (kg) * 1.23 (male) or * 1.04 (female) Characteristics of 1196 patients with a detectable HCV-RNA, according to HCV-treatment status (patients under HCV treatment at the time of analysis and patients with HCV reinfection excluded).